CORBIS

This brand name is authorized in Nigeria. It is also authorized in Ecuador.

Active ingredients

The drug CORBIS contains one active pharmaceutical ingredient (API):

1	Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE
	Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.
	Read more about Bisoprolol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4671	Tablet	CORBIS 10 TABLET TAB 10 mg	CORBIS 10 TABLET A4-4671 CORBIS 10 TABLET BISOPROLOL FUMARATE.List of excipients Calcium Hydrogen Phosphate Anhydrous BP Microcrystalline Cellulose (Avicel PH 112) BP Colloidal Silicon Dioxide (Aerosil 200) BP Pregelatinised Starch (Starch 1500) BP Magnesium Stearate BP Red Oxide of Iron USP/NF Titanium Dioxide BP Triacetin BP Hydroxypropyl Methyl Cellulose 5 cps BP Ethyl Cellulose BP Methanol BP Methylene Chloride BP Prescription Only Medicine (POM) PHILLIPS PHARMACEUTICALS (NIGERIA) LTD, APAPA-OSHODI EXPRESSWAY, IYANA-ISOLO LAGOS LAGOS UNICHEM LABORATORIES LIMITED, VILLAGE BHATALI KALAN BADDI DIST -SOLAN (H.P)INDIA. , India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB07	Bisoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	146-MEE-0314, 162-MEE-0314, 68-MEE-0214
NG	Registered Drug Product Database	A4-4671